Berra Yazar‐Klosinski

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein et al. · Nature Medicine · 2021 · 953 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

Peter Gasser, Dominique Holstein, Yvonne Michel et al. · The Journal of Nervous and Mental Disease · 2014 · 749 citations · Full text

Education, Behavioral Sciences, Psychiatry +15

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

Michael C. Mithoefer, Ann T. Mithoefer, Allison A. Feduccia et al. · The Lancet Psychiatry · 2018 · 438 citations

Medicine, Psychiatry, Psychology +17

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology · 2012 · 373 citations · Full text

Medicine, Psychiatry, Psychology +17

RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Michael C. Mithoefer, Allison A. Feduccia, Lisa Jerome et al. · Psychopharmacology · 2019 · 363 citations · Full text

Medicine, Psychiatry, Psychology +8